About Frank Perabo
Frank Perabo is a director at Dvant Pharma.
Experience
This experience comes from Frank Perabo's profile and from SEC filings. For roles taken from filings, the years are when the filings name Frank Perabo in the role, so the role may have started earlier or lasted longer.
MI
MacroGenics, Inc. Current
VP, Head of Clinical Development
2025 – Present
Dvant Pharma, Inc. Current
Chairperson of the Board
2024 – Present · Superior Township, MI
Develops cancer drugs for patients.
PL
Perabo Consulting, LLC.
Drug Development Consultant
2018 – 2025
TT
Tachyon Therapeutics
Chief Executive Officer & Chief Medical Officer (CEO/CMO)
2020 – 2024
MI
MAIA Biotechnology, Inc.
Co-Founder, President & Chief Medical Officer
2018 – 2019
BC
Barricade Therapeutics, Corp.
Founder & Chief Executive Officer
2018
EP
ESSA Pharma
Chief Medical Officer & Executive Vice President, Clinical Development
2014 – 2018
AP
Astellas Pharma
Executive Director
2006 – 2014
PG
P&S Partner, GmbH
Founder & Medical-Scientific Consultant
2002 – 2006
OG
Oncology World, GmbH
Scientific Director
2001 – 2002
UB
University Clinic Bonn
Associate Professor of Urology & Head, Urological Research Laboratory and Clinical Trial Centre
1998 – 2001
NN
National Cancer Institute (NCI)
Visiting Doctor
1999
MC
Memorial Sloan Kettering Cancer Center
Visiting Doctor
1999
UF
University of Freiburg
Resident Physician, Urology
1995 – 1998
TM
Technical University of Munich
Resident Physician, Surgery
1993 – 1995
Key Colleagues at Startups
The people Frank Perabo works with at each company, as listed on that company's latest Form D.
Dvant Pharma, Inc. · Form D, Oct 13, 2026
AK
Andrew Kocab
Chief Executive Officer and director
MN
Mukesh Nyati
Executive officer and director
VA
Vincent Alessi
Director
JA
Jim Adox
Director